Month: January 2026

VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) — SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) today announced the completion and launch of its fully offline GPS-denied navigation and laser-free target acquisition application on a defense made Tactical Edition smartphone. Built for contested environments, SPARC AI maintains operational navigation and reporting when GPS is denied, degraded, or spoofed, and enables camera-based target location generation without requiring a laser range finder or external equipment. Samsung’s Tactical Edition is built for military use and is typically procured through government and enterprise channels rather than public retail. SPARC AI installed its application on the Tactical Edition device supplied via its reseller, Precision Technical Defence, providing...

Golar LNG’s 4th Quarter 2025 results will be released before the market opens on Wednesday, February 25, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm London Time) on Wednesday February 25, 2026. The presentation will be available to download from the Investor Relations section at www.golarlng.com We recommend that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call by clicking on this link. We recommend connecting 10 minutes prior to the call start. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions...

MONTREAL, Jan. 27, 2026 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced today that its Board of Directors has approved a monthly dividend of C$0.01333 per common share (C$0.16 annually) for February 2026. This will be payable on February 17, 2026, to shareholders of record as of the close of business on February 9, 2026. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. About Dynacor Dynacor Group is an industrial ore processing company dedicated to producing gold sourced from artisanal miners. Since its...

Vancouver B.C., Jan. 27, 2026 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) welcomes the recent announcement by Governor Cox of Utah unveiling “Mission Critical” a mine-to-market state strategy for critical minerals, built with clarity, speed, and responsibility.  The state plans to approve five mining projects in 2026 and to bring a national lab to Utah by 2031 making Utah the No. 1 destination for critical mineral extraction and processing in the United States. In late 2025, uranium was added to the U.S. Government’s list of critical minerals deeming it vital to the U.S. economy.  Being on the critical minerals list can influence federal as well as state policy in several ways including: Fast track permittingDomestic mining and processing incentivesPrioritization...

Engagement of Xcalibur Smart Mapping to Accelerate Exploration Momentum Following Successful Public Listing VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) — One Bullion Ltd. (“One Bullion” or the “Company”) (TSXV: OBUL), a gold exploration company holding complete ownership of three highly prospective mining areas in Botswana, is pleased to announce that it has engaged Xcalibur Smart Mapping to conduct a comprehensive high resolution Airborne Magnetic Gradiometer and Radiometrics survey over both Vumba and Maitengwe projects, in the North-East and Central Districts of Botswana, respectively. The planned surveys represent a key milestone as the Company advances toward drill-ready targets in its 2026 exploration program. “These surveys are a critical step in systematically unlocking value across our portfolio and positioning...

PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, conducted a Type C meeting with the U.S. Food and Drug Administration (FDA) on January 21, 2026. The objective of this meeting was to review plans for the proposed Phase 2b study of zervimesine in dementia with Lewy bodies (DLB), a disease with no FDA-approved therapies. “We had a productive meeting with the FDA, during which we discussed clinically meaningful endpoints for the next Phase 2b study of mild-to-moderate DLB,” stated Anthony O. Caggiano, MD, PhD, Cognition’s chief medical officer. “We look forward to receiving meeting minutes later this quarter and continuing our dialogue with the FDA to advance clinical development...